Succ ès de traitement par Cabergoline d'une série de cas de cardiomyopathie du péripartum, incluant un cas critique nécessitant une assistance circulatoire mécanique

Ann Cardiol Angeiol (Paris). 2023 Jun 8;72(4):101610. doi: 10.1016/j.ancard.2023.101610. Online ahead of print.ABSTRACTPeripartum cardiomyopathy is a life-threatening condition that requires urgent diagnosis and management. Bromocriptine was established as disease specific therapy; less data is known about Cabergolin which is another prolactin secretion inhibitor. In this paper we report 4 peripartum cardiomyopathy cases treated successfully with Cabergoline, including a cardiogenic shock case requiring mechanical circulatory support.PMID:37300904 | DOI:10.1016/j.ancard.2023.101610
Source: Annales de Cardiologie et d'Angeiologie - Category: Cardiology Authors: Source Type: research